Overview: The treatment of dermatophytosis.
暂无分享,去创建一个
[1] H. Degreef,et al. Short-term itraconazole versus terbinafine in the treatmentof superficial dermatomycosis of the glabrous skin(tinea corporis or cruris) , 2000 .
[2] B. Elewski,et al. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. , 1998, Journal of the American Academy of Dermatology.
[3] S. Rand. Bioinstrumentation measurements versus clinical grading scales. , 1998, Journal of the American Academy of Dermatology.
[4] M. Lebwohl,et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. , 1998, Journal of the American Academy of Dermatology.
[5] A. Stary,et al. Fluconazole in the Treatment of Tinea corporis and Tinea cruris , 1998, Dermatology.
[6] G. Levy,et al. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus. , 1998, International journal of dermatology.
[7] H. Degreef,et al. Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks. , 1997, Journal of the American Academy of Dermatology.
[8] J. Faergemann,et al. A multicentre (double‐blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris , 1997, The British journal of dermatology.
[9] S. Rand. Clinical trials of the new antifungal drug therapies. , 1996, Journal of the American Academy of Dermatology.
[10] E. Difonzo,et al. A double‐blind comparison of itraconazole and fluconazole in tinea pedis and tinea manuum , 1995 .
[11] R. Hay,et al. A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 1OO mg/day in plantar‐type tinea pedis , 1995, The British journal of dermatology.
[12] J. Decroix,et al. TINEA PEDIS (MOCASSINTYPE) TREATED WITH ITRACONAZOLE , 1995, International journal of dermatology.
[13] M. Taha,et al. One‐week therapy with oral terbinafine in cases of tinea cruris/corporis , 1994, The British journal of dermatology.
[14] R. Pariser,et al. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. , 1994, Journal of the American Academy of Dermatology.
[15] N. Shear,et al. Antifungal agents: an overview. Part II. , 1994, Journal of the American Academy of Dermatology.
[16] D. Massart,et al. Two‐week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double‐blind, multicentre study , 1994, The British journal of dermatology.
[17] N. Shear,et al. Antifungal agents : an overview. II , 1994 .
[18] V. Voravutinon. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study. , 1993, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[19] R. Aguila,et al. Once‐weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis , 1992, Clinical and experimental dermatology.
[20] E. Evans,et al. Successful 2‐week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manuum , 1991, The British journal of dermatology.
[21] N. Zaias,et al. Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial. , 1990, Journal of the American Academy of Dermatology.
[22] R. Wit. A randomized double-blind multicentre comparative study of Lamisil(terbinafine) versus ketoconazole in tinea corporis , 1990 .
[23] J. Lachapelle,et al. Double‐Blind Comparison of Itraconazole with Griseofulvin in the Treatment of Tinea Corporis and Tinea Cruris , 1989, International journal of dermatology.
[24] R. Siegle,et al. Griseofulvin and Ketoconazole in the Treatment of Dermatophyte Infections , 1989, International journal of dermatology.
[25] E. Smith. Effect of investigator bias on clinical trials. , 1989, Archives of dermatology.
[26] Thomas B. Fitzpatrick,et al. Dermatology in general medicine , 1971 .